Results 101 to 110 of about 50,400 (305)

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies

open access: yesMovement Disorders, 2018
Background: The objective of this study was to investigate the discriminating value of a range of CSF α‐synuclein species for dementia with Lewy bodies compared with Alzheimer's disease, PD, and cognitively normal controls.
I. van Steenoven   +8 more
semanticscholar   +1 more source

Ocular Motor Abnormalities in Functional Neurological Disorder: A Video‐Oculography Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Functional neurological disorders (FND) can include various sensory, motor or cognitive symptoms. Eye movement recordings, measured through video‐oculography, could serve as biomarkers for characterizing these dysfunctions in FND.
Aude Sangare   +13 more
wiley   +1 more source

Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies

open access: yesNeurobiology of Disease, 2016
Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia after Alzheimer's disease. Although an increasing number of genetic factors have been connected to this debilitating condition, the proportion of cases that can be ...
Joshua T. Geiger   +16 more
doaj   +1 more source

Motor and Cognitive Outcome After Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease Harboring GBA1 Variant

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Deep brain stimulation (DBS) is effective for Parkinson's disease (PD); however, its efficacy varies with genetic background, such as the GBA1 variant—the causative gene of Gaucher disease—associated with increased PD risk and cognitive decline after subthalamic nucleus (STN)‐DBS.
Hikaru Kamo   +14 more
wiley   +1 more source

DEMENTIA WITH LEWY BODIES: A CASE REPORT

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Following the description of Lewy body spectrum disorders by Kosaka in 1980, dementia with Lewy bodies (DLB) which was considered as a rare cause of dementia before, is much more frequently recognized. DLB can be considered as being a member of spectrum
Sermin Kesebir   +3 more
doaj  

The Prevalence and Incidence of Dementia with Lewy Bodies: a Systematic Review

open access: yesCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2016
Background Population-based prevalence and incidence studies are essential for understanding the societal burden of dementia with Lewy bodies (DLB). Methods The MEDLINE and EMBASE databases were searched to identify publications addressing the incidence ...
D. Hogan   +9 more
semanticscholar   +1 more source

Basal Forebrain Volume and Concurrent Hallucinations and Mild Cognitive Impairment in Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Visual hallucinations (VH) and mild cognitive impairment (MCI) often co‐occur in Parkinson's Disease (PD). Each symptom in isolation is associated with cholinergic basal forebrain (BF) atrophy. However, it is unclear whether BF integrity relates to one symptom preferentially or to their co‐occurrence, and whether this relationship ...
Sabrina M. Adamo   +6 more
wiley   +1 more source

Video-Based Gait Analysis for Assessing Alzheimer’s Disease and Dementia with Lewy Bodies

open access: green, 2023
Diwei Wang   +4 more
openalex   +2 more sources

Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies

open access: yesPsychological Medicine, 2018
Background Dopaminergic imaging has high diagnostic accuracy for dementia with Lewy bodies (DLB) at the dementia stage. We report the first investigation of dopaminergic imaging at the prodromal stage.
Alan J. Thomas   +10 more
semanticscholar   +1 more source

Brain Imaging Changes Following Deep Brain Stimulation Patients with Parkinson's Disease: A Literature Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's Disease (PD) is a progressive neurodegenerative disorder primarily characterized by motor symptoms such as tremors, rigidity, and bradykinesia. Structural brain changes, including atrophy in the midbrain, basal ganglia, and cortical regions such as the frontal and temporal lobes, are observed in advanced stages.
Suraiya Mangra   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy